The UK’s Advertising Standards Authority (ASA) has banned five advertisements for testosterone testing after finding that they made misleading links between low testosterone and common health symptoms.

The adverts promoted Voy, an online healthcare provider. They appeared as posters and paid social media campaigns and included claims about low sex drive, fatigue, irritability and low motivation.

The ASA published its ruling on November 18. It said the adverts exaggerated the connection between several symptoms and low testosterone levels.

Why the ASA Banned the Advertisements

The regulator investigated the adverts after receiving complaints from members of the public.

Some of the posters asked questions such as “Low sex drive?” and “Lost his spark?” They then suggested that low testosterone could explain these symptoms and encouraged consumers to buy an at-home blood test.

The ASA accepted that low testosterone can cause certain symptoms. However, it said several other symptoms in the adverts can have many different causes.

The regulator concluded that the adverts could lead consumers to believe that low testosterone was a likely explanation without enough evidence.

The Disputed Claim About One in Four Men

One of the Facebook adverts claimed that low testosterone affects one in four men over 30.

Voy defended the statement and submitted research to support it. However, the ASA found that the study did not justify the claim as presented.

The regulator noted that the research included men who already showed symptoms of androgen deficiency. It therefore did not provide a reliable basis for claiming that one in four men over 30 had the condition.

The ASA ruled that the claim was misleading and lacked adequate evidence.

Voy Responds to the Ruling

Voy argued that its adverts used conditional language and did not claim that the symptoms always resulted from low testosterone.

The company said the tests could help people understand their hormone levels.

However, the ASA upheld the complaints about several adverts. It instructed Voy not to use the ads again in their current form.

The regulator also told the company not to exaggerate the link between common symptoms and low testosterone or make unsupported claims about how many men have low levels.

Wider Concerns About Men’s Health Advertising

The ruling forms part of a wider ASA investigation into advertisements for low testosterone tests and services.

The regulator has raised concerns about companies using symptoms such as fatigue, anxiety and reduced motivation to promote hormone testing.

The decision does not ban testosterone testing or advertising for related services. Instead, it makes clear that companies must support their health claims with reliable evidence and avoid misleading consumers.

News World Magazine